Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Alzheimer's Disease

Free Subscription Articles published in Science Retrieve available abstracts of 39 articles: HTML format

Single Articles

March 2024
1. PILLER C
   'Damning' FDA inspection report undermines Alzheimer's drug.
   Science. 2024;383:1165-1166.
   PubMed     Abstract available
   
   
   December 2023
2. GOLDE TE, Levey AI
   Immunotherapies for Alzheimer's disease.
   Science. 2023;382:1242-1244.
   PubMed     Abstract available
   
   
   November 2023
3. PILLER C
   Brain games?
   Science. 2023;382:754-759.
   PubMed     Abstract available
   
   
   October 2023
4. PILLER C
   Probe of Alzheimer's studies finds 'egregious misconduct'.
   Science. 2023;382:251-252.
   PubMed     Abstract available
   
   
   September 2023
5. BALUSU S, Horre K, Thrupp N, Craessaerts K, et al
   MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease.
   Science. 2023;381:1176-1182.
   PubMed     Abstract available
   
   
   
6. SIRKIS DW, Yokoyama JS
   Role for cell death pathway in Alzheimer's disease.
   Science. 2023;381:1156-1157.
   PubMed     Abstract available
   
   
   
7. AGUZZI A, Kampmann M
   Neurodegeneration enters the era of functional genomics.
   Science. 2023;381:eadk5693.
   PubMed     Abstract available
   
   
   August 2023
8. COUZIN-FRANKEL J
   Side effects loom over Alzheimer's drugs.
   Science. 2023;381:466-467.
   PubMed     Abstract available
   
   
   July 2023
9. ZHANG ZY, Harischandra DS, Wang R, Ghaisas S, et al
   TRIM11 protects against tauopathies and is down-regulated in Alzheimer's disease.
   Science. 2023;381:eadd6696.
   PubMed     Abstract available
   
   
   May 2023
10. TRAVIS J
    Latest Alzheimer's antibody is 'not a miracle drug'.
    Science. 2023;380:571.
    PubMed     Abstract available
    
    
    April 2023
11. PILLER C
    Report on trial death stokes Alzheimer's drug fears.
    Science. 2023;380:122-123.
    PubMed     Abstract available
    
    
    
12. COUZIN-FRANKEL J
    Promising Alzheimer's therapies shrink brains.
    Science. 2023;380:19.
    PubMed     Abstract available
    
    
    January 2023
13. COUZIN-FRANKEL J
    Alzheimer's drug approval gets a mixed reception.
    Science. 2023;379:126-127.
    PubMed     Abstract available
    
    
    December 2022
14. COUZIN-FRANKEL J, Piller C
    Alzheimer's drug stirs excitement-and concerns.
    Science. 2022;378:1030-1031.
    PubMed     Abstract available
    
    
    November 2022
15. PILLER C
    Whistleblower finds possible misconduct in his own papers.
    Science. 2022;378:694-695.
    PubMed     Abstract available
    
    
    
16. ENDO F, Kasai A, Soto JS, Yu X, et al
    Molecular basis of astrocyte diversity and morphology across the CNS in health and disease.
    Science. 2022;378:eadc9020.
    PubMed     Abstract available
    
    
    September 2022
17. HOFFMANN HM
    Boosting cognition with a hormone.
    Science. 2022;377:1042-1043.
    PubMed     Abstract available
    
    
    August 2022
18. ASHE KH
    Alzheimer's target still viable but untested.
    Science. 2022;377:935.
    PubMed    
    
    
    
19. SELKOE D, Cummings J
    News story miscasts Alzheimer's science.
    Science. 2022;377:934-935.
    PubMed    
    
    
    
20. COOPER YA, Teyssier N, Drager NM, Guo Q, et al
    Functional regulatory variants implicate distinct transcriptional networks in dementia.
    Science. 2022;377:eabi8654.
    PubMed     Abstract available
    
    
    July 2022
21. PILLER C
    Research backing experimental Alzheimer's drug was first target of suspicion.
    Science. 2022;377:363.
    PubMed    
    
    
    
22. PILLER C
    Research backing experimental Alzheimer's drug was first target of suspicion.
    Science. 2022;377:363.
    PubMed    
    
    
    
23. PILLER C
    Blots on a field?
    Science. 2022;377:358-363.
    PubMed     Abstract available
    
    
    
24. ZHOU X, Sumrow L, Tashiro K, Sutherland L, et al
    Mutations linked to neurological disease enhance self-association of low-complexity protein sequences.
    Science. 2022;377:eabn5582.
    PubMed     Abstract available
    
    
    January 2022
25. YANG Y, Arseni D, Zhang W, Huang M, et al
    Cryo-EM structures of amyloid-beta 42 filaments from human brains.
    Science. 2022;375:167-172.
    PubMed     Abstract available
    
    
    December 2021
26. LESLIE M
    Blood condition may guard against Alzheimer's.
    Science. 2021;374:1425.
    PubMed     Abstract available
    
    
    October 2021
27. SELKOE DJ
    Alzheimer's drugs: Does reducing amyloid work?-Response.
    Science. 2021;374:545-546.
    PubMed    
    
    
    
28. THAMBISETTY M, Howard R, Glymour MM, Schneider LS, et al
    Alzheimer's drugs: Does reducing amyloid work?
    Science. 2021;374:544-545.
    PubMed    
    
    
    
29. SPIRES-JONES T
    Toward a holistic model of Alzheimer'sHow Not to Study a Disease: The Story of Alzheimer's Karl Herrup MIT Press, 2021. 272 pp.
    Science. 2021;374:267.
    PubMed     Abstract available
    
    
    August 2021
30. BLENNOW K
    Phenotyping Alzheimer's disease with blood tests.
    Science. 2021;373:626-628.
    PubMed    
    
    
    
31. SELKOE DJ
    Treatments for Alzheimer's disease emerge.
    Science. 2021;373:624-626.
    PubMed    
    
    
    July 2021
32. SERVICK K
    Alzheimer's drug approval spotlights blood tests.
    Science. 2021;373:373-374.
    PubMed    
    
    
    June 2021
33. SERVICK K
    Alzheimer's drug approved despite murky results.
    Science. 2021;372:1141.
    PubMed    
    
    
    December 2020
34. NAKAMURA T, Oh CK, Liao L, Zhang X, et al
    Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease.
    Science. 2020 Dec 3. pii: science.aaw0843. doi: 10.1126/science.aaw0843.
    PubMed     Abstract available
    
    
    November 2020
35. DARWICH NF, Phan JM, Kim B, Suh E, et al
    Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau.
    Science. 2020;370.
    PubMed     Abstract available
    
    
    October 2020
36. BARTELS T, De Schepper S, Hong S
    Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases.
    Science. 2020;370:66-69.
    PubMed     Abstract available
    
    
    
37. SIERKSMA A, Escott-Price V, De Strooper B
    Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets.
    Science. 2020;370:61-66.
    PubMed     Abstract available
    
    
    
38. NEDERGAARD M, Goldman SA
    Glymphatic failure as a final common pathway to dementia.
    Science. 2020;370:50-56.
    PubMed     Abstract available
    
    
    August 2020
39. SUZUKI K, Elegheert J, Song I, Sasakura H, et al
    A synthetic synaptic organizer protein restores glutamatergic neuronal circuits.
    Science. 2020;369.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.